Increase in clinical prevalence of AIDS implies increase in unsafe medical injections

International Journal of STD and AIDS

Volumn 20, Issue 5, 2009, Pages 295-299

  Reid, S ^a,b  

^a UNIVERSITY OF NEVADA   (United States)

^b NONE   (United States)

Author keywords

HIV; Iatrogenic; Nosocomial; Parenteral

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; DISEASE COURSE; DISEASE TRANSMISSION; EXPOSURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MEDICAL CARE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SAFETY; SENSITIVITY ANALYSIS; WORLD HEALTH ORGANIZATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICA; AFRICA SOUTH OF THE SAHARA; DEVELOPING COUNTRIES; EQUIPMENT REUSE; HUMANS; INFECTIOUS DISEASE TRANSMISSION, PROFESSIONAL-TO-PATIENT; INJECTIONS; PREVALENCE; RISK FACTORS; SYRINGES;

EID: 66449114045     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2008.008441     Document Type: Review

References (46)

1. Gisselquist D. Points to Consider: Responses to HIV/AIDS in Africa, Asia and the Caribbean. London: Adonis & Abbey, 2008
2. Shisana O, Rehle T, Simbayi L, et al. South African National HIV Prevalence, HIV Incidence, Behavior and Communication Survey, 2005. Durban: HSRC Press, 2005
3. 3 Hiemstra R, Rabie H, Schaaf H, et al. Unexplained HIV-1 infection in children - documenting cases and assessing for possible risk factors. S Afr Med J 2004;94:188-193 (Pubitemid 38380115)
4. 4 Rehle T, Shisana O, Pillay V, Zuma K, Puren A, Parker W. National HIV incidence measures - new insights into the South African epidemic. S Afr Med J 2007;97:194-199 (Pubitemid 46455885)
5. Hendriksen E, Pettifor A, Lee S, Coates T, Rees H. Predictors of condom use among young adults in South Africa: the reproductive health and HIV research unit national youth survey. Am J Public Health 2007;97:1241-1248
6. Giesecke J. Modern Infectious Disease Epidemiology. London: Arnold, 2002
7. Kane A, Lloyd J, Zaffran M, Simonsen L, Kane M. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. Bull WHO 1999;77:801-807
8. Hauri A, Hutin Y, Armstrong G. Contaminated injections in health care settings. In: Ezzati M, Lopez E, Rodgers A, Murray C, eds. Comparative Quantification of Health Risks, Vol.2. Geneva: WHO, 2004:1803-1850
9. Senate Health, Education, Labor and Pensions Committee - Africa AIDS. Washington, D.C.: US Senate, 27 March 2003
10. Gadde R. Fighting the spread of HIV/AIDS by preventing syringe reuse. 2004 - XIV International AIDS Conference 2004. Abstract no. A10530
11. 11 Baggaley R, Boily M, White R, Alary M. Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis. AIDS 2006;20:805-812 (Pubitemid 43731561)
12. 12 Gisselquist D, Upham G, Potterat J. Efficiency of human immunodeficiency virus transmission through injections and other medical procedures: evidence, estimates, and unfinished business. Infect Control Hosp Epidemiol 2006;27:944-952 (Pubitemid 44449254)
13. Mermin J, Musinguzi J, Opio A, et al. Risk factors for recent HIV infection in Uganda. JAMA 2008;300:540-549
14. 14 Lopman B, Garnett G, Mason P, Gregson S. Individual level injection history: a lack of association with HIV incidence in rural Zimbabwe. PLoS Med 2005;2:e37 (Pubitemid 40418901)
15. 15 Cardo D, Culver D, Ciesielksi C, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. N Engl J Med 1997;337:1485-1490 (Pubitemid 27495773)
16. 16 Schmid G, Buve A, Mugyenyi P, et al. Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections. Lancet 2004;363:482-488 (Pubitemid 38210068)
17. Kaplan E, Heimer R. A model-based estimate of HIV infectivity via needle sharing. J Acquir Immune Defic Syndr 1992;5:1116-1118
18. 18 Hudgens M, Longini I, Vanichseni S, et al. Subtype-specific transmission probabilities for human immunodeficiency virus among injecting drug users in Bangkok, Thailand. Am J Epidemiol 2002;155:159-168 (Pubitemid 34072739)
19. 19 Hoelscher M, Riedner G, Hemed Y, Wagner H, Korte R, von Sonnenburg F. Estimating the number of HIV transmission through reused syringes and needles in the Mbeya Region, Tanzania. AIDS 1994;8:1609-1615 (Pubitemid 24335100)
20. 20 Priddy F, Tesfaye F, Mengistu Y, et al. Potential for medical transmission of HIV in Ethiopia. AIDS 2005;19:348-350 (Pubitemid 40396570)
21. Apetrei C, Becker J, Metzger M, et al. Potential for HIV transmission through unsafe injections. AIDS 2006;20:1074-1076
22. 22 Rich J, Dickinson B, Carney J, Fisher A, Heimer R. Detection of HIV-1 nucleic acid and HIV-1 antibodies in needles and syringes used for non-intravenous injection. AIDS 1998;12:2345-2350 (Pubitemid 28526415)
23. Hoffman I, Jere C, Taylor T, et al. The effect of plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration. AIDS 1999;13:487-494
24. 24 Toossi Z, Mayanja-Kizza H, Hirsch C, et al. Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients. Clin Exp Immunol 2001;123:233-238 (Pubitemid 32174774)
25. 25 Dyer J, Kazembe P, Vernazza P, et al. High levels of Human Immunodeficiency Virus Type 1 in blood and semen of seropositive men in sub-Saharan Africa. J Infect Dis 1998;177:1742-1746 (Pubitemid 28243608)
26. 26 Walson J, Brown E, Otieno P, et al. Morbidity among HIV-1-infected mothers in Kenya: prevalence and correlates of illness during 2-year postpartum follow-up. J Acquir Immune Defic Syndr 2007;46:208-215 (Pubitemid 47482617)
27. 27 Ole-Nguyaine S, Crump A, Kibiki G, et al. HIV-associated morbidity, mortality and diagnostic testing opportunities among inpatients at a referral hospital in northern Tanzania. Ann Trop Med Parasitol 2004;98:171-179 (Pubitemid 38388885)
28. USAID. HIV/AIDS Surveillance Data Base: South Africa. See [http://hivaidssurveillancedb.org/hivdb/RecordSelPage.aspx] 2008 (last checked 12 November 2008)
29. Pillaya K, Colvinb M, Williams R, Coovadiaa M. Impact of HIV-1 infection in South Africa. Arch Dis Child 2001;85:50-51
30. 30 Pruss-Ustun A, Rapiti E, Hutin Y. Estimation of the global burden of disease attributable to contaminated sharps injuries among health-care workers. Am J Ind Med 2005;48:482-490 (Pubitemid 41746865)
31. Tibandebage P, Wangwe S, Mujinja P, Bail R, Shepard D. Expenditures on HIV/AIDS in Tanzania. Confronting AIDS 1998;289-296
32. Cornia G, Zagonari F. The HIV and AIDS impact on the rural and urban economy. In: Cornia G. ed. AIDS, Public Policy and Child Well-Being. Florence: Innocenti Research Centre, 2002
33. 33 Badri M, Maartens G, Mandalia S, et al. Cost-effectiveness of highly active antiretroviral therapy in South Africa. PLoS Med 2006;3:pe4 (Pubitemid 43204370)
34. World Bank. IFAD strategy paper on HIV/AIDS for East and Southern Africa. [http://www.ifad.org/operations/regional/pf/aids-2.htm] 1998 (last checked 12 November 2008)
35. Sidley P. South African health service must strengthen infection control measures. BMJ News Roundup 2004;328:366
36. Mermin J, Musinguzi J, Opio A, et al. Risk factors for recent HIV infection in Uganda. JAMA 2008;300:540-549
37. Logez S, Hutin Y, Somda P, Thuault J, Holloway K. Safer injections following a new national medicine policy in the public sector, Burkina Faso 1995-2000. BMC Public Health 2005;5:136
38. Star Syringe. Uganda ban on standard syringes comes into force. Press Release, July 4 2007
39. National Agency for Food and Drug Administration & Control (NAFDAC), Nigeria. Public notice on introduction of auto disable syringes. [http://www.nafdacnigeria.net/] 2008 (last checked 24 October 2008)
40. SIGN. Report of the Global Injection Safety and Infection Control Meeting, 23-25 October 2007. Geneva: WHO, 2008
41. Simonsen L, Kane A, Lloyd J, Zaffran M, Kane M. Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull WHO 1999;77:789-800
42. SIGN. Final Report of the 2005 Annual Safe Injection Global Network Meeting. Hanoi, Vietnam: SIGN 2006
43. 43 Abdala N, Stephens P, Griffith B, Heimer R. Survival of HIV-1 in syringes. J Acquir Immune Defic Syndr Hum Retrovirol 1999;20:73-80 (Pubitemid 29045473)
44. 44 Gisselquist D, Friedman E, Potterat J, Minkin S, Brody S. Four policies to reduce HIV transmission through unsterile health care. Int J STD AIDS 2003;14:717-722 (Pubitemid 37372222)
45. UNAIDS. HIV and AIDS estimates and data, 2007 and 2001. [http://data.unaids.org/pub/GlobalReport/2008/jc1510-2008-global-report-pp211- 234-en.pdf] 2008 (last checked 20 November 2008)
46. WHO. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector: progress report 2008 [http://www.unaidsrstesa.org/ userfiles/file/towards-universal-access-report-2008%5B1%5D(1).pdf ] June 2008 (last checked 20 November 2008)